Amir Toor Department of Internal Medicine Virginia Commonwealth University- Massey Cancer Center Biography Publications Institution JoVE Articles Amir Toor has not added a biography. If you are Amir Toor and would like to personalize this page please email our Author Liaison for assistance. Publications Favorable Outcomes in Patients with High Donor-Derived T Cell Count After In Vivo T Cell-Depleted Reduced-Intensity Allogeneic Stem Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Oct, 2011 | Pubmed ID: 22005648 Activated NKT Cells and NK Cells Render T Cells Resistant to Myeloid-derived Suppressor Cells and Result in an Effective Adoptive Cellular Therapy Against Breast Cancer in the FVBN202 Transgenic Mouse Journal of Immunology (Baltimore, Md. : 1950). Jul, 2011 | Pubmed ID: 21670315 Comment on "Cutting Edge: CD8+ T Cell Priming in the Absence of NK Cells Leads to Enhanced Memory Responses" Journal of Immunology (Baltimore, Md. : 1950). Jun, 2011 | Pubmed ID: 21597038 Randomized Phase III Trial of Pegfilgrastim Versus Filgrastim After Autologus Peripheral Blood Stem Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. May, 2010 | Pubmed ID: 20045479 Rearrangements of the MLL Gene Are Influenced by DNA Secondary Structure, Potentially Mediated by Topoisomerase II Binding Genes, Chromosomes & Cancer. Sep, 2009 | Pubmed ID: 19530238 Dose Intense Therapy for Relapsed Lymphoproliferative Disorders: the More Things Change, the More They Are the Same Leukemia & Lymphoma. May, 2009 | Pubmed ID: 19452313 Impaired NHEJ Function in Multiple Myeloma Mutation Research. Jan, 2009 | Pubmed ID: 19028508 Tandem Autologous Stem Cell Transplantation for Patients with Primary Refractory or Poor Risk Recurrent Hodgkin Lymphoma Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. May, 2007 | Pubmed ID: 17448919 Alefacept in Corticosteroid Refractory Graft Versus Host Disease: Early Results Indicate Promising Activity The Journal of Dermatological Treatment. 2007 | Pubmed ID: 17365261 The Administration of Polymerized Human Hemoglobin (Pyridoxylated) to a Jehovah's Witness After Submyeloablative Stem Cell Transplantation Complicated by Delayed Graft Failure Comprehensive Therapy. 2006 | Pubmed ID: 17435270 Cardiac Nonamyloidotic Immunoglobulin Deposition Disease Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. Feb, 2006 | Pubmed ID: 16341150 Post-transplant Air-leak Syndrome British Journal of Haematology. Sep, 2004 | Pubmed ID: 15352978 Overexpression of the NOTCH Ligand JAG2 in Malignant Plasma Cells from Multiple Myeloma Patients and Cell Lines Blood. Dec, 2004 | Pubmed ID: 15292061 Favourable Results with a Single Autologous Stem Cell Transplant Following Conditioning with Busulphan and Cyclophosphamide in Patients with Multiple Myeloma British Journal of Haematology. Mar, 2004 | Pubmed ID: 15009065 BEAM Allogeneic Transplantation for Patients with Hodgkin's Disease Who Relapse After Autologous Transplantation is Safe and Effective Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Mar, 2003 | Pubmed ID: 12652468 Infection--an Underappreciated Cause of Bone Pain in Multiple Myeloma British Journal of Haematology. Mar, 2003 | Pubmed ID: 12648075 Myeloma of the Central Nervous System: Association with High-risk Chromosomal Abnormalities, Plasmablastic Morphology and Extramedullary Manifestations British Journal of Haematology. Apr, 2002 | Pubmed ID: 11918539 ABO Mismatch May Affect Engraftment in Multiple Myeloma Patients Receiving Nonmyeloablative Conditioning Transfusion. Feb, 2002 | Pubmed ID: 11896336 Predicting Long-term (> or = 5 Years) Event-free Survival in Multiple Myeloma Patients Following Planned Tandem Autotransplants British Journal of Haematology. Jan, 2002 | Pubmed ID: 11841419 Expansão ex vivo de células tumorais T-reativa por Meios de 1/Ionomycin Bryostatin eo Common Gamma Cadeia Formulação Citocinas Maciej Kmieciak1, Amir Toor2, Laura Graham3, Harry D. Bear3, Masoud H. Manjili1 1Department of Microbiology & Immunology, Virginia Commonwealth University- Massey Cancer Center, 2Department of Internal Medicine, Virginia Commonwealth University- Massey Cancer Center, 3Department of Surgery, Virginia Commonwealth University- Massey Cancer Center JoVE 2381 Immunology and Infection
Expansão ex vivo de células tumorais T-reativa por Meios de 1/Ionomycin Bryostatin eo Common Gamma Cadeia Formulação Citocinas Maciej Kmieciak1, Amir Toor2, Laura Graham3, Harry D. Bear3, Masoud H. Manjili1 1Department of Microbiology & Immunology, Virginia Commonwealth University- Massey Cancer Center, 2Department of Internal Medicine, Virginia Commonwealth University- Massey Cancer Center, 3Department of Surgery, Virginia Commonwealth University- Massey Cancer Center JoVE 2381 Immunology and Infection